Blood-pressure-related disease is a global health priority

American Journal of Hypertension

Volumn 21, Issue 8, 2008, Pages 843-844

  MacMahon, Stephen ^a   Alderman, Michael H ^b   Lindholm, Lars H ^c   Liu, Lisheng ^d   Sanchez, Ramiro A ^e   Seedat, Yackoob K ^f  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c UMEÅ UNIVERSITY   (Sweden)

^d FUWAI HOSPITAL   (China)

^e FAVALORO UNIVERSITY   (Argentina)

^f UNIVERSITY OF KWAZULU NATAL   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIURETIC AGENT;

ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; DISABILITY; DRUG COST; EDITORIAL; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTENSION; MALIGNANT HYPERTENSION; MORTALITY; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; SOCIOECONOMICS; STROKE;

BLOOD PRESSURE; HEALTH PRIORITIES; HUMANS; HYPERTENSION; WORLD HEALTH;

EID: 47749087129     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1038/ajh.2008.223     Document Type: Editorial

References (11)

1. Lawes CMM, Vander Hoorn S, Rodgers A, et al., for the International Society of Hypertension. Global burden of blood-pressure-related disease, 2001. Lancet 2008; 371:1513-1518.
2. Murray CJL, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997; 349:1498-1504.
3. World Health Organization. Preventing Chronic Diseases: A Vital Investment. World Health Organization: Geneva, Switzerland, 2005.
4. Adeyi O, Smith O, Robles S. Public Policy and the Challenge of Chronic Noncommunicable Diseases. World Bank: Washington, DC, 2007.
5. Connor MD, Walker R, Modi G, Warlow CP. Burden of stroke in black populations in sub-Saharan Africa. Lancet Neurol 2007; 6:269-278.
6. Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials. Lancet 2003; 362:1527-1535.
7. PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet 2001; 358:1033-1041.
8. McFadyen JF, ed. International Drug Price Indicator Guide 2006. Management Sciences for Health: Cambridge, MA, 2007.
9. China Salt Substitute Study Collaborative Group. Salt substitution: a low-cost strategy for blood pressure control among rural Chinese: a randomized, controlled trial. J Hypertension 2007; 25:2011-2018.
10. Kitahata MM, Tegger MK, Wagner EH, Holmes KK. Comprehensive health care for people infected with HIV in developing countries. BMJ 2002; 325:954-957.
11. Riley S. The Cardiovascular Market Outlook to 2011. Business Insights: London, 2006.